BLMS News and Press, Bloomios Inc

Quarterly Revenue More Than Doubles to $2.7 Million Year-to-Date Revenue up 96% to $5.4 Million SANTA BARBARA, CA / ACCESSWIRE / August 30, 2023 / Bloomios, Inc. (OTCQB:BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics ...

Bloomios Appoints Kevin Henry as National Sales Director PR Newswire SANTA BARBARA, Calif. , June 9, 2023 /PRNewswire/ -- Bloomios, Inc. (OTCQB: BLMS), a leading innovator in contract manufacturing of hemp-derived cannabinoid & mushroom edibles, cosm...

2023-06-01 16:22:05 ET Bloomios press release ( OTCQB:BLMS ): Q1 net loss per share $0.11. Revenue of $2.75M. Outlook: Q2 revenues to exceed $3M. For further details see: Bloomios reports Q1 results

Bloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million PR Newswire Annualized Run Rate Hits $11.0 Million vs. $6.1 million in 2022, Driven by Increased Order Flow and Production Capacity Q2 2023 Outlook of Revenues to Exceed $3 mill...

Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer PR Newswire SANTA BARBARA, Calif. , March 27, 2023 /PRNewswire/ -- Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler o...

California-based hemp product manufacturer Bloomios Inc. (OTCQB: BLMS) last week acquired gummy maker Infusionz for $23.5 million in a bid to rapidly expand its gummy manufacturing footprint. Infusionz owner, the Florida-based Upexi (Nasdaq: UPXI), provided “sig...

Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer PR Newswire Transaction Expected to Double Production Capacity and Supports Entry of Direct-to-Consumer Market SANTA BARBARA, Calif. , Oct. 27, 2022 /PRNewswire/ -- B...

Upexi Announces Sale of Select CBD Assets for $23.5 Million PR Newswire Transaction accelerates our Amazon and DTC eCommerce brand focused strategy , strengthens balance sheet and provides additional capital flexibility to invest in further acquisitions Com...

Santa Barbara, California--(Newsfile Corp. - October 20, 2022) - Bloomios, Inc. (OTCQB: BLMS), a leading hemp derived cannabinoid supplements and nutraceutical contract manufacturer specializing in full service product development, R&D and compliance solutions, has been invited to presen...

Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients PR Newswire SANTA BARBARA, Calif. , Aug. 4, 2022 /PRNewswire/ -- Blo...